XML 17 R4.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Consolidated Statements of Income (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Income Statement [Abstract]        
Revenue $ 851,573 $ 815,634 $ 2,491,310 $ 2,379,725
Salaries, wages and benefits (including equity-based compensation expense of $6,031, $9,467, $25,257 and $27,014, respectively) 462,169 428,147 1,359,857 1,265,427
Professional fees 51,478 48,498 147,146 142,236
Supplies 30,412 29,623 87,286 84,153
Rents and leases 11,736 12,389 36,002 36,141
Other operating expenses 128,787 112,137 377,203 322,900
Depreciation and amortization 47,468 37,641 143,495 110,054
Interest expense, net 36,619 29,924 100,939 86,297
Debt extinguishment costs     1,269  
Legal settlements expense     3,504  
Loss on impairment   10,459 1,452 11,459
Gain on sale of property     (8,715)  
Transaction, legal and other costs 42,919 8,249 138,416 17,187
Total expenses 811,588 717,067 2,387,854 2,075,854
Income before income taxes 39,985 98,567 103,456 303,871
Provision for income taxes 1,668 27,199 18,139 72,916
Net income 38,317 71,368 85,317 230,955
Net income attributable to noncontrolling interests (2,071) (3,236) (10,570) (7,958)
Net income attributable to Acadia Healthcare Company, Inc. $ 36,246 $ 68,132 $ 74,747 $ 222,997
Earnings per share attributable to Acadia Healthcare Company, Inc. stockholders:        
Basic $ 0.4 $ 0.74 $ 0.82 $ 2.44
Diluted $ 0.4 $ 0.74 $ 0.82 $ 2.42
Weighted-average shares outstanding:        
Basic 90,414 91,720 90,794 91,571
Diluted 90,584 92,188 91,255 92,119